EUVIMEDEUVIMED entdecken
Open Access

SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma

Eun-Jeong Jeong, Yeon Soo Kim, Yujin Lee, Jae-Sung Ryu, Yung Hyun Choi, Eunjeong Kim

Oncology Research · 2026 · 34 (6) · 1-10

DOI: 10.32604/or.2026.078376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Eun-Jeong Jeong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Konyang University, Daejeon, Republic of Korea. Hauptthemen laut MEDLINE: Cisplatin, Biomarkers, Tumor, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinBiomarkers, TumorSquamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsHumansPrognosisAntineoplastic AgentsCell Line, TumorGene Expression Regulation, NeoplasticCell ProliferationFemaleTumor MicroenvironmentMaleApoptosisDrug Resistance, Neoplasm

Stichwörter der Autor:innen

Sideroflexin 3 (SFXN3)The Cancer Genome Atlas (TCGA)bioinformaticsbiomarkerhead and neck squamous cell carcinoma (HNSCC)prognosistumor microenvironment

Substanzen

CisplatinBiomarkers, TumorAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Konyang University, Daejeon, Republic of Korea.
  • Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Korea University, Seoul, Republic of Korea.
  • BK21 FOUR KNU Creative BioResearch Group, Department of Biology, College of Natural Sciences, Kyungpook National University, Daegu, Republic of Korea.
  • New Drug Development Center, Osong Medical Innovation Foundation, Cheongju, Republic of Korea.
  • Basic Research Laboratory for the Regulation of Microplastic-Mediated Diseases and Anti-Aging Research Center, Dong-eui University, Busan, Republic of Korea.
  • Department of Biochemistry, College of Korean Medicine, Dong-eui University, Busan, Republic of Korea.

Zitieren

APA

Jeong, E. J., Kim, Y. S., Lee, Y., Ryu, J. S., Choi, Y. H., & Kim, E. (2026). SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma. Oncology Research, 34(6), 1-10. https://doi.org/10.32604/or.2026.078376

Vancouver

Jeong EJ, Kim YS, Lee Y, Ryu JS, Choi YH, Kim E. SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma. Oncology Research. 2026;34(6):1-10. doi:10.32604/or.2026.078376

BibTeX
@article{Jeong2026,
  author = {Jeong, Eun-Jeong and Kim, Yeon Soo and Lee, Yujin and Ryu, Jae-Sung and Choi, Yung Hyun and Kim, Eunjeong},
  title = {SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma},
  journal = {Oncology Research},
  year = {2026},
  volume = {34},
  number = {6},
  pages = {1--10},
  doi = {10.32604/or.2026.078376}
}
Kostenlos starten →